Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interhospital variation in Medicare spending for infections after coronary artery bypass grafting and surgical aortic valve replacement.

JTCVS open·2026
Same author

Humanistic Machines: Designing Devices for People With Heart Failure With a Focus on Multidisciplinary Human Factors Research.

JACC. Heart failure·2026
Same author

The Ninth Annual STS-Pedimacs Report: Pediatric VAD Outcomes and the Expanding Role of Biventricular Support.

The Annals of thoracic surgery·2026
Same author

Aortic insufficiency and right heart failure in patients treated with durable left ventricular assist devices after preoperative support with microaxial flow devices.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same author

Statewide Quality Collaborative As a Forum for Change: Promoting Adoption of Multiarterial Grafting in Coronary Artery Bypass Graft Surgery.

The Annals of thoracic surgery·2026
Same author

Correction: Association Between Cardiac Rehabilitation and 1-Year Mortality by Frailty Level in Medicare Beneficiaries.

Circulation. Population health and outcomes·2026

Related Experiment Video

Updated: Jun 24, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Vancomycin use during left ventricular assist device support.

Rachel F Eyler1, Simona O Butler, Paul C Walker

  • 1Department of Pharmacy Services, University of Michigan Health System and College of Pharmacy, Ann Arbor, Michigan 48109-0008, USA.

Infection Control and Hospital Epidemiology
|March 24, 2009
PubMed
Summary
This summary is machine-generated.

Vancomycin was frequently used for extended durations during left ventricular assist device (LVAD) implantations. Strategies are needed to optimize vancomycin use in LVAD patients.

More Related Videos

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Related Experiment Videos

Last Updated: Jun 24, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Left ventricular assist devices (LVADs) are crucial for heart failure management.
  • Antibiotic prophylaxis is standard in LVAD procedures, but optimal duration and agents require definition.
  • Vancomycin is frequently used, necessitating evaluation of its usage patterns.

Purpose of the Study:

  • To assess the frequency and duration of vancomycin administration in patients undergoing LVAD implantation.
  • To identify common indications for empirical vancomycin use in this population.

Main Methods:

  • Retrospective review of 93 left ventricular assist device implantations.
  • Analysis of vancomycin prophylaxis and empirical therapy duration.
  • Identification of reasons for empirical vancomycin administration.

Main Results:

  • Vancomycin prophylaxis averaged 10.5 days.
  • Empirical vancomycin was administered in 87% of cases for a mean of 9.8 days (median 8 days).
  • Isolated leukocytosis and driveline drainage were primary indications for empirical vancomycin.

Conclusions:

  • Current vancomycin use during LVAD implantation is frequent and prolonged.
  • Strategies to refine vancomycin utilization in LVAD support are warranted.
  • Further research should focus on optimizing antibiotic stewardship in LVAD recipients.